Atlas Trials

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior

Clinical trial NCT07193901 · RECRUITING

Trial details

NCT number
NCT07193901
Sponsor
Sichuan Purity Pharmaceutical Technology Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder (MDD
Start date
2025-05-27
Primary completion
2026-06-01
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.